NK

NantKwest
NASDAQ

实时行情|Nasdaq Last Sale

2.990
+0.040
+1.36%
盘后: 2.990 0 0.00% 16:00 04/09 EDT
开盘
3.060
昨收
2.950
最高
3.090
最低
2.910
成交量
76.29万
成交额
--
52周最高
9.90
52周最低
0.9500
市值
2.94亿
市盈率(TTM)
-4.2315
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测NK价格均价为3.500,最高价位3.500,最低价为3.500。

EPS

NK 新闻

更多
  • 白俄罗斯总理建议欧亚经济联盟大力推动去美元化进程
  • 央视 · 2小时前
  • 摩根大通大幅下调对美国经济前景的预期
  • 新浪财经综合 · 2小时前
  • 2.3万亿美元并非最后一搏,美联储还能继续放水!
  • 新浪财经综合 · 2小时前
  • 美股战“疫”小记:美股在这个早春都经历了什么?
  • 新浪财经综合 · 2小时前

所属板块

生物技术和医学研究
+1.63%
制药与医学研究
+0.82%

热门股票

代码
价格
涨跌幅

NK 简况

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company is focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. Its immuno-oncology NK platform has multiple modes to induce cell death against the tumor or infected cell by direct killing by binding to stress ligands expressed by the diseased cell with the release of toxic granules directly into the tumor cell; antibody mediated killing by binding to antibodies administered in combination and enhancing the cancer killing effect of the administered antibody, enabling targeted cell killing through antibody dependent cellular cytotoxicity (ADCC), and target activated killing by binding to known or newly discovered tumor-specific antigens expressed on the surface of tumor cells and inducing cell death by the release of toxic granules directly into the tumor cell and by the release of cytokines and chemokines.
展开

微牛提供Nantkwest Inc(NASDAQ-NK)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的NK股票新闻,以帮助您做出投资决策。